Literature DB >> 1695559

Neonatal myasthenia gravis: antigenic specificities of antibodies in sera from mothers and their infants.

S J Tzartos1, A Efthimiadis, E Morel, B Eymard, J F Bach.   

Abstract

Transient neonatal myasthenia gravis (MG) is a human model of passively transferred MG. In an effort to understand the characteristics of the most pathogenic antibodies in MG, we studied the fine antigenic specificities of anti-AChR antibodies in sera from 21 MG mothers (nine of which had transiently transferred the disease) and 17 of their infants. Although in a few cases significant differences in antibody specificities were observed between mothers and infants, whether myasthenic or not, generally the antigenic specificities of the antibodies in sera from infants were very similar to those of their mothers. Furthermore, no characteristic differences were detected between the antibody repertoires of mothers who transferred the disease and those who did not.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1695559      PMCID: PMC1535194          DOI: 10.1111/j.1365-2249.1990.tb03296.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  Localization of the main immunogenic region of human muscle acetylcholine receptor to residues 67-76 of the alpha subunit.

Authors:  S J Tzartos; A Kokla; S L Walgrave; B M Conti-Tronconi
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

2.  Neonatal myasthenia gravis: a new clinical and immunologic appraisal on 30 cases.

Authors:  E Morel; B Eymard; B Vernet-der Garabedian; C Pannier; O Dulac; J F Bach
Journal:  Neurology       Date:  1988-01       Impact factor: 9.910

3.  Role of the main immunogenic region of acetylcholine receptor in myasthenia gravis. An Fab monoclonal antibody protects against antigenic modulation by human sera.

Authors:  S J Tzartos; D Sophianos; A Efthimiadis
Journal:  J Immunol       Date:  1985-04       Impact factor: 5.422

4.  Monoclonal antibodies against the main immunogenic region of the acetylcholine receptor. Mapping on the intact molecule.

Authors:  A A Kordossi; S J Tzartos
Journal:  J Neuroimmunol       Date:  1989-06       Impact factor: 3.478

5.  Antiacetylcholine receptor antibody in neonatal myasthenia gravis.

Authors:  J O Donaldson; A S Penn; R P Lisak; O Abramsky; T Brenner; D L Schotland
Journal:  Am J Dis Child       Date:  1981-03

6.  Mapping of surface structures of electrophorus acetylcholine receptor using monoclonal antibodies.

Authors:  S J Tzartos; D E Rand; B L Einarson; J M Lindstrom
Journal:  J Biol Chem       Date:  1981-08-25       Impact factor: 5.157

7.  Neonatal myasthenia gravis: clinical and immunological study of seven mothers and their newborn infants.

Authors:  E Bartoccioni; A Evoli; C Casali; C Scoppetta; P Tonali; C Provenzano
Journal:  J Neuroimmunol       Date:  1986-08       Impact factor: 3.478

8.  Monoclonal antibodies used to probe acetylcholine receptor structure: localization of the main immunogenic region and detection of similarities between subunits.

Authors:  S J Tzartos; J M Lindstrom
Journal:  Proc Natl Acad Sci U S A       Date:  1980-02       Impact factor: 11.205

9.  Characteristics of monoclonal antibodies to denatured Torpedo and to native calf acetylcholine receptors: species, subunit and region specificity.

Authors:  S Tzartos; L Langeberg; S Hochschwender; L W Swanson; J Lindstrom
Journal:  J Neuroimmunol       Date:  1986-01       Impact factor: 3.478

10.  Myasthenia gravis: monoclonal antihuman acetylcholine receptor antibodies used to analyze antibody specificities and responses to treatment.

Authors:  P J Whiting; A Vincent; J Newsom-Davis
Journal:  Neurology       Date:  1986-05       Impact factor: 9.910

View more
  4 in total

Review 1.  The main immunogenic region (MIR) of the nicotinic acetylcholine receptor and the anti-MIR antibodies.

Authors:  S J Tzartos; M T Cung; P Demange; H Loutrari; A Mamalaki; M Marraud; I Papadouli; C Sakarellos; V Tsikaris
Journal:  Mol Neurobiol       Date:  1991       Impact factor: 5.590

2.  Pregnancy in a Patient With Primary Membranous Nephropathy and Circulating Anti-PLA2R Antibodies: A Case Report.

Authors:  Laith Al-Rabadi; Rivka Ayalon; Ramon G Bonegio; Jennifer E Ballard; Alan M Fujii; Joel M Henderson; David J Salant; Laurence H Beck
Journal:  Am J Kidney Dis       Date:  2015-12-29       Impact factor: 8.860

3.  Association of neonatal myasthenia gravis with antibodies against the fetal acetylcholine receptor.

Authors:  B Vernet-der Garabedian; M Lacokova; B Eymard; E Morel; M Faltin; J Zajac; O Sadovsky; M Dommergues; P Tripon; J F Bach
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

4.  Direct proof of the in vivo pathogenic role of the AChR autoantibodies from myasthenia gravis patients.

Authors:  Gregory Kordas; George Lagoumintzis; Sotirios Sideris; Konstantinos Poulas; Socrates J Tzartos
Journal:  PLoS One       Date:  2014-09-26       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.